Prospective randomized trial of enoxaparin, pentoxifylline and ursodeoxycholic acid for prevention of radiation-induced liver toxicity
Palabras clave : 
Liver
Pentoxifylline and ursodeoxycholic acid
Fecha de publicación: 
2014
Editorial : 
Public Library of Science
ISSN: 
1932-6203
Nota de editorial: 
Attribution 4.0 International (CC BY 4.0)
Cita: 
Seidensticker M, Seidensticker R, Damm R, Mohnike K, Pech M, et al. Prospective Randomized Trial of Enoxaparin, Pentoxifylline and Ursodeoxycholic Acid for Prevention of Radiation-Induced Liver Toxicity. PLoS ONE 2014;9(11): e112731.
Resumen
The post-therapeutic application of PTX, UDCA and low-dose LMWH significantly reduced the extent and incidence fRILI at 6 weeks after radiotherapy. The development of subsequent fRILI at 12 weeks (4 weeks after cessation of PTX, UDCA and LMWH during weeks 1-8) in the treatment group was comparable to the control group thus supporting the observation that the agents mitigated fRILI.

Ficheros en este registro:
Fichero: 
pone.0112731.pdf
Descripción: 
Tamaño: 
3,05 MB
Formato: 
Adobe PDF


Los ítems de Dadun están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.